Clinical optimization platform

Licensed · 503A · HIPAA

Peptide compound

GLP / GIP / Glucagon Triple Agonist

Triple-receptor agonist (retatrutide-class) for advanced metabolic research.

$140Starting · per vial

— Tracked fulfillment · COA included · Discreet packaging

GLP / GIP / Glucagon Triple Agonist

Purity

>99%

Form

Lyophilized

Storage

-20°C

Grade

Research

— Overview

GLP / GIP / Glucagon Triple Agonist at a glance.

A triple-receptor agonist targeting GLP-1, GIP, and glucagon pathways simultaneously. Research interest centers on the combined effects of these three incretin and counter-regulatory hormones on energy expenditure, glucose handling, and adipose-tissue dynamics.

— Want supervision?

Pair GLP / GIP / Glucagon Triple Agonist with a
physician-designed protocol.

Stria Performance and Complete tiers include physician-prescribed peptides with comprehensive labs and quarterly follow-up. Take the assessment to see which fits.